Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study

Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study

Background The aim of this study was to assess the efficacy and safety of amrubicin for previously treated malignant pleural mesothelioma. Methods The eligibility criteria were: previously treated unresectable malignant pleural mesothelioma; performance status 0–1; age ≤ 75; adequate hematological,...

Full description

Bibliographic Details
Main Authors: Takaya Ikeda, Shinnosuke Takemoto, Hiroaki Senju, Hiroshi Gyotoku, Hirokazu Taniguchi, Midori Shimada, Yosuke Dotsu, Yasuhiro Umeyama, Hiromi Tomono, Takeshi Kitazaki, Masaaki Fukuda, Hiroshi Soda, Hiroyuki Yamaguchi, Minoru Fukuda, Hiroshi Mukae
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Thoracic Cancer
Subjects:
Amrubicin
chemotherapy
mesothelioma
Online Access:https://doi.org/10.1111/1759-7714.13490

Internet

https://doi.org/10.1111/1759-7714.13490

Similar Items